Biologics had a whopping quarter, Advanced Dressings saw strong gains and External Devices continue to show minimal gains due to traditional NPWT holding down the segment.

The global AWC market is split geographically, with the US accounting for just over half, followed by Europe and then ROW, due to the US using higher technology products and their allowed reimbursement. SmartTRAK has noted shifts in market share, largely driven by currency movements. In Q123, there was less of an impact. From Q221 to Q123, the US went from 52.6% share to 53.1%, Europe from 27.9% to 28.6% and ROW from 19.5% to 18.2%.

Among the many topics covered in detail in SmartTRAK's comprehensive Q123 Advanced Wound Care Market Recap* are:

• Complete Q123 Advanced Wound Care Market Overview
• SmartTRAK's Expert Market Analysis and Insights
• All AWC Companies' News, Revenues, Data, Charts and Market Shares
• WW Advanced Dressings: Acceleration of Continued Solid Growth
• Biologics: An Impressive Quarter
  
  • Skin Substitutes/CTPs
  • Topical Delivery/Drug
  • Collagen/Active Dressings
• External Devices: Single-use NPWT and Topical Oxygen Therapy Drive Growth
• Growth Analysis – Currency Having a Less Strong Impact
  • Growth Details for Key Companies in Q123
• Other Notable Q123 AWC Events

3M remained the global revenue leader in the Q123 WW AWC market, with Smith+Nephew (SNN) is in second place and Mölnlycke rounding out the top three,  with revenues of ...

Read the entire Q123 AWC Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

New SaaS technology offering delivers competitive advantage in rapidly changing Ambulatory Surgery Center market.

SmartTRAK, the leading global Medtech business and market software intelligence solution in the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets, is pleased to announce the release of ASC Insights, the industry’s first-ever commercially available platform-based solution for the growing Ambulatory Surgery Center (ASC) market. ASC Insights provides real-time insights and rich data to help clients better understand market trends and accelerate commercial growth strategies.

In recent years, the Orthopedic ASC market, valued at over $10 billion, has undergone a significant transition as surgeries increasingly shift from traditional inpatient settings to outpatient ASCs. This shift necessitates that Medtech companies explore new ways to stay informed about myriad data sources and market shifts to drive their commercial growth strategies.

The ASC Insights offering is an extension of the SmartTRAK platform, encompassing comprehensive market analyses and proprietary qualitative insights on trends, as well as readily extractable quantitative metrics. Alternatively, enterprise customers can seamlessly integrate these metrics into their business intelligence platforms. Subscribers to SmartTRAK ASC Insights gain access to a historical news archive, recaps of changes in key facility ownership and information on technologies and reimbursement. Furthermore, customers receive valuable Daily Updates, ensuring up-to-date and timely coverage of noteworthy ASC industry developments. They also enjoy on-demand, direct access to SmartTRAK expert analysts.

New products and technologies in Shoulder Replacement and the Extremities Fixation Segments planted the seeds for sequential growth in the Q123 Extremities Market

The US Extremities Market grew 7.8% in Q123 with new products and continued recovery of elective procedures encouraging growth despite concerns about a looming recession. While headwinds such as supply chain constraints, economic challenges and staffing shortages could darken the forecast, SmartTRAK expects the Extremities Market to weather these issues and continue to experience strong growth through 2023.

Among the many topics covered in detail in SmartTRAK's comprehensive Q123 Extremities Market Recap* are:

• Complete Q123 Extremities Market Overview
• SmartTRAK's Expert Market Analysis and Insights
• All Company News, Revenues, Data, Charts and Shares
• New Products and Technologies That are Planting the Seeds for Growth in Shoulders
• Extremities Fixation Closes the Quarter on High with Solid Returns
• Q123 Regulatory Highlights

Both US Extremities Fixation subsegments, Upper Extremities Fixation and Foot Ankle Fixation, ended the first quarter of 2023 with ...

Read the entire Q123 Extremities Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

The success or failure of medical technology often hinges on dynamics occurring within healthcare policy and reimbursement. In this article, SmartTRAK highlights policy and reimbursement themes from SAWC Spring 2023

SAWC Spring 2023 welcomed clinicians, researchers and industry to Washington, DC, to share knowledge and network on the latest developments in advanced wound care. While the attention centered on advances in disease management and technological innovation, SmartTRAK noted compelling discussions involving healthcare policy and reimbursement that may have been missed by some industry participants.

In this article, which can be downloaded here, SmartTRAK explores coverage and payment dynamics surrounding the following topics:

• Artificial Intelligence: Implications for Advanced Wound Care
  • Artificial Intelligence (AI) is the hot topic of the day. Companies seek to capitalize on it, governments want to regulate it, some workers fear it ...
    
• Medicare Advantage: Growing Concerns About Claims Denials
  • Medicare Advantage plans are under fire for reportedly restricting access to medically necessary care ...
    
• Topical Oxygen Therapy: Reconsidering Local MAC Coverage Policy
  • In 2017, industry stakeholders requested that CMS remove the non-coverage of topical oxygen therapies (TOT) from the National Coverage Determination (NCD) Manual ...
    

Artificial Intelligence (AI) is the hot topic of the day. Companies seek to capitalize on it, governments want to regulate it and some workers fear it. Given the attention, it is fitting that sessions touching on AI bookended SAWC Spring 2023. Daniel Kraft, MD, opened the keynote address with captivating slides on how medicine is positioned within the fourth industrial revolution, where robotics, big data and AI are transforming care and leading to ...

To download and read the complete "Underlying Dynamics in Healthcare Policy and Reimbursement" by Terry Hayslett, Senior Analyst, Advanced Wound Care, just click the button below.

Among the many topics covered in detail in SmartTRAK's comprehensive Q123 Total Joints Market Recap* are:

• Complete Q123 Total Joints Market Overview
• SmartTRAK's Expert Market Analysis and Insights
• All Company News, Revenues, Data, Charts and Shares
• Technologies and Procedure Recovery Elevating Hip Growth
• The Ongoing March Towards Cementless Knees
• Deals and Financing Highlights
• Q123 Regulatory Highlights

Will this momentum continue throughout 2023? SmartTRAK believes underlying demand for hip and knee replacement surgery will ...

Read the entire Q123 Total Joints Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

With Smith+Nephew having dominated the wound debridement market for over a decade, SmartTRAK looks at how 2023 could be a year where we see the first signs of disruption.

The WW Wound Debridement Market is forecast to grow at a five-year CAGR of ~5.1%, according to SmartTRAK estimates. Although Smith+Nephew (SNN) has long dominated this market with more than 74% share, SmartTRAK believes 2023 could be a year of disruption in wound debridement as multiple players across a range of segments are poised to see financial returns after years of commercial progress. It is also worth noting that sharp debridement accounts for over half of the debridement procedures in the US, so the route to market growth is clear. 

• Complete Q123 US Surgical Matrices Market Overview
• SmartTRAK's Expert Market Analysis and Insights
• All Company News, Revenues, Data, Charts and Shares
• US Surgical Matrices Market Shuffles Leadership
• US Breast Matrices: Holding Steady
• US Hernia Repair Matrices Market: Another Solid Quarter
• Q123 Clinical/Regulatory Highlights

The US Surgical Matrices Market grew in Q123 with more strength in the Hernia Matrices segment, due to the continued growth of biosynthetic matrices and TELA Bio’s OviTex as physicians use them for ...

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

The ISASS 2023 annual meeting is taking place this week in San Francisco, and SmartTRAK is excited to be in attendance. Our team of spine experts will be roaming the event, providing our subscribers with up-to-the-minute news directly from the show floor. To ensure you're well-informed ahead of the meeting, below is a selection of recent spine news meticulously curated by our expert analysts at SmartTRAK.

If you're interested in receiving 30 days of COMPLIMENTARY daily real-time updates delivered to your inbox each morning, simply click here. Additionally, if if you are interested in learning more about The Future of Spine Enabling Technology for 2023, click here to read the article.

New Products:

• Orthofix*
  

  Orthofix noted that the Company launched the Lattus Lateral Access System and the Fathom Pedicle-Based Retractor System during Q123, which both address what the Company estimated to be a $1.8B MIS spine market.
  

• REFLECT Scoliosis System* - Globus*

  Globus Medical has announced FDA approval of REFLECT Scoliosis Correction System, the company's first humanitarian device. The non-fusion system, using a flexible cord instead of rigid metal rods, corrects scoliosis in young pts while preserving motion and allowing for growth.
  

Merger mayhem of Q422 continues and the Spine enabling tech space heats up with new navigation products and some robotics players seeing record-breaking sales and unit placements.

The Q422 WW Spine Enabling Tech Market was up +13.6% YoY, according to SmartTRAK Financial Dashboard. Medtronic (MDT) remained the market leader, followed by Globus Medical (GMED) and other enabling tech competitors like Brainlab and Stryker (SYK). For detailed Q422 revenues and shares by company in the US, EU and ROW, see SmartTRAK Spine Enabling Tech Financial Dashboard*.

• Complete Q422 Spine Enabling Tech Performance Recap
• Mighty Mergers in Q422 and Q123
  • SeaSpine and Orthofix Take the Plunge
  • Globus and NuVasive Join Forces in Q123
    
• Other Q422 Collaborations
  • ZimVie and Brainlab
  • Spineart and eCential Robotics
  • Captiva Spine and REMEX Medical
• Q422 Augmented Reality and Navigation Regulatory Highlights

Read the entire Q422 Spine Enabling Tech Market Recap, including SmartTRAK's expert analysis, news, data, charts, revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

Boost YOUR Success with Better Market Intelligence Solutions

In these uncertain times, the Medtech Industry is facing economic challenges, which have resulted in countless layoffs, early retirements and stressful budget cuts. As a result, many departments are left without proper staffing, creating major gaps in subject matter expertise and strategic insights. But times of pressure demand push-back from those determined to come out stronger on the other side, which is why now, more than ever, is the time to double down on your investments in market intelligence solutions and better technology.

Technology is a critical investment that can help companies reduce costs and increase efficiency. According to a recent survey by Gartner, an astounding 40% of CFOs say they plan to increase their IT budgets, even in times of economic uncertainty. Automation is also seen as a deflationary force that can help companies boost productivity and reduce costs while maintaining strong barriers to entry, what Morgan Stanley analysts call “deflation enablers.”

SmartTRAK’s Insights-as-a-Service solution has the potential to drive significant savings while also providing a competitive edge for your growth strategies. Just look at some of the potential results investments in SmartTRAK can provide companies:

• 20 to 25% increase the productivity of knowledge workers
• 25 - 35% reduction in time searching and gathering information with a searchable record of knowledge
• 3.5 – 6.5 hours of increased value-added time per week

But the proof is in the pudding. With the kinds of challenges that Medtech companies are facing today, SmartTRAK offers necessary solutions to help ease the burden of inflation. The SmartTRAK insights platformcombined with our subject matter experts can work as an extension of your market intelligence team, keeping you in-the-know and more productive than ever as you weather the economic storm.

If your organization is grappling with the kinds of budget challenges we mentioned while striving for double-digit growth, allow SmartTRAK to help. With a simple discovery call, our team can demonstrate the value and positive impacts of your company’s market intelligence spend. Using our SmartTRAK ROI Modeling tool, we can uncover invisible productivity and consolidation opportunities that can result in cost savings, greater efficiency and a positive ROI. All you have to do is click the button below to reach out to schedule.